We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current INKT market cap is 38.62M. The company's latest EPS is USD -0.5678 and P/E is -1.76.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.22M | -5.5M | -3.83M | -3.07M | -1.89M |
| Net Income | -5.12M | -5.46M | -3.81M | -2.7M | -1.81M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.2M | 0 | 0 | 0 | 0 |
| Operating Income | -22.28M | -14.64M | -28.36M | -30.95M | -22.92M |
| Net Income | -23.8M | -16.24M | -30.21M | -27.99M | -22.46M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.46M | 4.55M | 6.89M | 10.32M | 7.38M |
| Total Liabilities | 21.04M | 22.61M | 27.19M | 26.9M | 24.93M |
| Total Equity | -13.58M | -18.06M | -20.3M | -16.58M | -17.55M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.31M | 4.56M | 40.24M | 21.47M | 4.55M |
| Total Liabilities | 37.64M | 58.43M | 16.47M | 21.87M | 22.61M |
| Total Equity | -36.33M | -53.87M | 23.78M | -401k | -18.06M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -12.73M | -15.76M | -2.54M | -4.83M | -7.83M |
| Investing | -74k | -74k | N/A | N/A | N/A |
| Financing | -408k | -407k | 5.01M | 10.81M | 10.82M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -14.94M | -8.34M | -12.83M | -18.87M | -15.76M |
| Investing | -426k | -95k | -249k | -250k | -74k |
| Financing | 11.44M | 11.11M | 49.26M | -155k | -407k |
| Market Cap | 38.62M |
| Price to Earnings Ratio | -1.76 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 11.75 |
| Price to Book Ratio | -2.19 |
| Dividend Yield | - |
| Shares Outstanding | 39.55M |
| Average Volume (1 week) | 143.37k |
| Average Volume (1 Month) | 88.83k |
| 52 Week Change | -7.88% |
| 52 Week High | 1.90 |
| 52 Week Low | 0.4632 |
| Spread (Intraday) | 0.05 (5.09%) |
| Company Name | MiNK Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://minktherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
